experimental group:sintilimab

A single-arm, single-center prospective study of the efficacy and safety of Sintilimab in combination with conventional antitumor therapy for recurrent or metastatic cervical, endometrial, and ovarian cancers

phase II exploratory clinical trial of sintilimab maintenance therapy after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma